000 | 01761 a2200397 4500 | ||
---|---|---|---|
005 | 20250513132408.0 | ||
264 | 0 | _c19980106 | |
008 | 199801s 0 0 eng d | ||
022 | _a0148-916X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaw, W W | |
245 | 0 | 0 |
_aStudies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic nude mice. _h[electronic resource] |
260 |
_bInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _cSep 1997 |
||
300 |
_a345-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdoptive Transfer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aClofazimine _xtherapeutic use |
650 | 0 | 4 |
_aDapsone _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aInterferon-gamma _xtherapeutic use |
650 | 0 | 4 |
_aLeprostatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aLeprosy _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
650 | 0 | 4 |
_aRifamycins _xtherapeutic use |
700 | 1 | _aTomioka, H | |
700 | 1 | _aSato, K | |
700 | 1 | _aSaito, H | |
773 | 0 |
_tInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _gvol. 65 _gno. 3 _gp. 345-51 |
|
999 |
_c9371137 _d9371137 |